detalle del documento
IDENTIFICACIÓN

oai:pubmedcentral.nih.gov:8251...

Tema
Research Articles
Autor
Bhumkar, Akshay Magnan, Chloe Lau, Derrick Jun, Eugene Soh Wei Dzamko, Nicolas Gambin, Yann Sierecki, Emma
Langue
en
Editor

John Wiley and Sons Inc.

Categoría

Wiley-Blackwell Online Open

Año

2021

fecha de cotización

1/12/2023

Palabras clave
amplification methods α‐synuclein patients parkinson detection disease
Métrico

Resumen

α‐Synuclein aggregation is a hallmark of Parkinson's disease and a promising biomarker for early detection and assessment of disease progression.

The prospect of a molecular test for Parkinson's disease is materializing with the recent developments of detection methods based on amplification of synuclein seeds (e.g. RT‐QuIC or PMCA).

Here we adapted single‐molecule counting methods for the detection of α‐synuclein aggregates in cerebrospinal fluid (CSF), using a simple 3D printed microscope.

Single‐molecule methods enable to probe the early events in the amplification process used in RT‐QuIC and a precise counting of ThT‐positive aggregates.

Importantly, the use of single‐molecule counting also allows a refined characterization of the samples and fingerprinting of the protein aggregates present in CSF of patients.

The fingerprinting of size and reactivity of individual aggregate shows a unique signature for each PD patients compared to controls and may provide new insights on synucleinopathies in the future.

Bhumkar, Akshay,Magnan, Chloe,Lau, Derrick,Jun, Eugene Soh Wei,Dzamko, Nicolas,Gambin, Yann,Sierecki, Emma, 2021, Single‐Molecule Counting Coupled to Rapid Amplification Enables Detection of α‐Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients, John Wiley and Sons Inc.

Compartir

Fuente

Artículos recomendados por ES/IODE IA

High-Frequency Repetitive Magnetic Stimulation at the Sacrum Alleviates Chronic Constipation in Parkinson’s Patients
magnetic stimulation parkinson’s significant patients scale sacrum pd hf-rms chronic constipation scores
The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation
bladder cancer pfk-1 zeb1 lactylation glycolysis inhibits lactate glucose bc pfk-1 cancer lactylation cells bladder